Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib

DSpace Repository

Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib

Author: Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Ruediger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W.; Schubert, Joerg; Einsele, Hermann; Haenel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Joerg; Hofmann, Wolf-Karsten; Hochhaus, Andreas; Mueller, Martin C.
Tübinger Autor(en):
Kanz, Lothar
Published in: Haematologica (2014), Bd. 99, H. 9, S. 1441-1447
Verlagsangabe: Ferrata Storti Foundation
Language: English
Full text: http://dx.doi.org/10.3324/haematol.2013.096537
ISSN: 0390-6078
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)